Increasing evidence has indicated natural transspecies transmission of gammaretroviruses; however, viral-host interactions after initial xeno-exposure remain poorly understood. Potential association of xenotropic murine leukemia virus-related virus (XMRV) in patients with prostate cancer and chronic fatigue syndrome has attracted broad interests in this topic. Although recent studies have indicated that XMRV is unlikely a human pathogen, further understanding of XMRV xenoinfection would allow in vivo modeling of the initial steps of gammaretroviral interspecies transmission, evolution and dissemination in a new host population. In this study, we monitored the long-term consequences of XMRV infection and its possible vertical transmission in a permissive foreign host, wild-derived Mus pahari mice. One year post-infection, XMRV-infected mice showed no notable pathological changes, while proviral DNA was detected in three out of eight mice. XMRV-infected mice remained seropositive throughout the study although the levels of gp70 Env- and p30 capsid-specific antibodies gradually decreased. When vertical XMRV transmission was assessed, no viremia, humoral immune responses nor endogenization were observed in nine offspring from infected mothers, yet one offspring was found PCR-positive for XMRV-specific sequences. Amplified viral sequences from the offspring showed several mutations, including one amino acid deletion in the receptor binding domain of Env SU. Our results therefore demonstrate long-term asymptomatic infection, low incidence of vertical transmission and limited evolution of XMRV upon transspecies infection of a permissive new host, Mus pahari.
References
[1]
Hardy WD Jr, Old LJ, Hess PW, Essex M, Cotter S (1973) Horizontal transmission of feline leukaemia virus. Nature 244: 266–269.
[2]
Portis JL, McAtee FJ, Hayes SF (1987) Horizontal transmission of murine retroviruses. J Virol 61: 1037–1044.
[3]
Buffett RF, Grace JT Jr, DiBerardino LA, Mirand EA (1969) Vertical transmission of murine leukemia virus through successive generations. Cancer Res 29: 596–602.
[4]
Duggan J, Okonta H, Chakraborty J (2004) Vertical transmission of a murine retrovirus, ts1. Viral Immunol 17: 266–278.
[5]
Fiebig U, Hartmann MG, Bannert N, Kurth R, Denner J (2006) Transspecies transmission of the endogenous koala retrovirus. J Virol 80: 5651–5654.
[6]
Lieber MM, Sherr CJ, Todaro GJ, Benveniste RE, Callahan R, et al. (1975) Isolation from the asian mouse Mus caroli of an endogenous type C virus related to infectious primate type C viruses. Proc Natl Acad Sci U S A 72: 2315–2319.
[7]
Martin J, Herniou E, Cook J, O'Neill RW, Tristem M (1999) Interclass transmission and phyletic host tracking in murine leukemia virus-related retroviruses. J Virol 73: 2442–2449.
[8]
Hanger JJ, Bromham LD, McKee JJ, O'Brien TM, Robinson WF (2000) The nucleotide sequence of koala (Phascolarctos cinereus) retrovirus: a novel type C endogenous virus related to Gibbon ape leukemia virus. J Virol 74: 4264–4272.
[9]
Tarlinton R, Meers J, Hanger J, Young P (2005) Real-time reverse transcriptase PCR for the endogenous koala retrovirus reveals an association between plasma viral load and neoplastic disease in koalas. J Gen Virol 86: 783–787.
[10]
Miyazawa T, Shojima T, Yoshikawa R, Ohata T (2011) Isolation of koala retroviruses from koalas in Japan. J Vet Med Sci 73: 65–70.
[11]
Kawakami TG, Huff SD, Buckley PM, Dungworth DL, Synder SP, et al. (1972) C-type virus associated with gibbon lymphosarcoma. Nat New Biol 235: 170–171.
[12]
Parks WP, Scolnick EM, Noon MC, Watson CJ, Kawakami TG (1973) Radioimmunoassay of mammalian type-C polypeptides. IV. Characterization of woolly monkey and gibbon viral antigens. Int J Cancer 12: 129–137.
[13]
Snyder SP, Dungworth DL, Kawakami TG, Callaway E, Lau DT (1973) Lymphosarcomas in two gibbons (Hylobates lar) with associated C-type virus. J Natl Cancer Inst 51: 89–94.
[14]
Patience C, Patton GS, Takeuchi Y, Weiss RA, McClure MO, et al. (1998) No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys. Lancet 352: 699–701.
[15]
Martin U, Steinhoff G, Kiessig V, Chikobava M, Anssar M, et al. (1998) Porcine endogenous retrovirus (PERV) was not transmitted from transplanted porcine endothelial cells to baboons in vivo. Transpl Int 11: 247–251.
[16]
Paradis K, Langford G, Long Z, Heneine W, Sandstrom P, et al. (1999) Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science 285: 1236–1241.
[17]
Martina Y, Marcucci KT, Cherqui S, Szabo A, Drysdale T, et al. (2006) Mice transgenic for a human porcine endogenous retrovirus receptor are susceptible to productive viral infection. J Virol 80: 3135–3146.
[18]
Rasheed S, Gardner MB, Chan E (1976) Amphotropic host range of naturally occuring wild mouse leukemia viruses. J Virol 19: 13–18.
[19]
Stoye JP, Coffin JM (1987) The four classes of endogenous murine leukemia virus: structural relationships and potential for recombination. J Virol 61: 2659–2669.
[20]
Svoboda J, Hejnar J, Geryk J, Elleder D, Vernerova Z (2000) Retroviruses in foreign species and the problem of provirus silencing. Gene 261: 181–188.
[21]
Kozak CA (2010) The mouse “xenotropic” gammaretroviruses and their XPR1 receptor. Retrovirology 7: 101.
[22]
Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, et al. (2006) Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2: e25.
[23]
Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, et al. (2009) Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 326: 585–589.
[24]
Lo SC, Pripuzova N, Li B, Komaroff AL, Hung GC, et al. (2010) Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proc Natl Acad Sci U S A 107: 15874–15879.
[25]
Aloia AL, Sfanos KS, Isaacs WB, Zheng Q, Maldarelli F, et al. (2010) XMRV: a new virus in prostate cancer? Cancer Res 70: 10028–10033.
[26]
Oakes B, Tai AK, Cingoz O, Henefield MH, Levine S, et al. (2010) Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences. Retrovirology 7: 109.
[27]
Sato E, Furuta RA, Miyazawa T (2010) An Endogenous Murine Leukemia Viral Genome Contaminant in a Commercial RT-PCR Kit is Amplified Using Standard Primers for XMRV. Retrovirology 7: 110.
[28]
Hue S, Gray ER, Gall A, Katzourakis A, Tan CP, et al. (2010) Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology 7: 111.
[29]
Sakuma T, Hue S, Squillace KA, Tonne JM, Blackburn PR, et al. (2011) No Evidence of XMRV in Prostate Cancer Cohorts in the Midwestern United States. Retrovirology 8: 23.
[30]
Paprotka T, Delviks-Frankenberry KA, Cingoz O, Martinez A, Kung HJ, et al. (2011) Recombinant origin of the retrovirus XMRV. Science 333: 97–101.
[31]
Lyu MS, Kozak CA (1996) Genetic basis for resistance to polytropic murine leukemia viruses in the wild mouse species Mus castaneus. J Virol 70: 830–833.
[32]
Yan Y, Knoper RC, Kozak CA (2007) Wild mouse variants of envelope genes of xenotropic/polytropic mouse gammaretroviruses and their XPR1 receptors elucidate receptor determinants of virus entry. J Virol 81: 10550–10557.
[33]
Sakuma T, Tonne JM, Squillace KA, Ohmine S, Thatava T, et al. (2011) Early events in retrovirus XMRV infection of the wild-derived mouse Mus pahari. J Virol 85: 1205–1213.
[34]
Groom HC, Yap MW, Galao RP, Neil SJ, Bishop KN (2010) Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors. Proc Natl Acad Sci U S A 107: 5166–5171.
[35]
Yan Y, Buckler-White A, Wollenberg K, Kozak CA (2009) Origin, antiviral function and evidence for positive selection of the gammaretrovirus restriction gene Fv1 in the genus Mus. Proc Natl Acad Sci U S A 106: 3259–3263.
[36]
Kozak CA (1985) Analysis of wild-derived mice for Fv-1 and Fv-2 murine leukemia virus restriction loci: a novel wild mouse Fv-1 allele responsible for lack of host range restriction. J Virol 55: 281–285.
[37]
Kozak CA (1985) Susceptibility of wild mouse cells to exogenous infection with xenotropic leukemia viruses: control by a single dominant locus on chromosome 1. J Virol 55: 690–695.
[38]
Kozak CA, O'Neill RR (1987) Diverse wild mouse origins of xenotropic, mink cell focus-forming, and two types of ecotropic proviral genes. J Virol 61: 3082–3088.
[39]
Buffett RF, Grace JT Jr, DiBerardino LA, Mirand EA (1969) Vertical transmission of murine leukemia virus. Cancer Res 29: 588–595.
[40]
Melief CJ, Louie S, Schwartz RS (1975) Ecotropic leukemia viruses in congenic C57BL mice: natural dissemination by milk-borne infection. J Natl Cancer Inst 55: 691–698.
[41]
Gardner MB, Chiri A, Dougherty MF, Casagrande J, Estes JD (1979) Congenital transmission of murine leukemia virus from wild mice prone to the development of lymphoma and paralysis. J Natl Cancer Inst 62: 63–70.
[42]
Sharpe AH, Hunter JJ, Ruprecht RM, Jaenisch R (1989) Maternal transmission of retroviral disease and strategies for preventing infection of the neonate. J Virol 63: 1049–1053.
[43]
Fass D, Davey RA, Hamson CA, Kim PS, Cunningham JM, et al. (1997) Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution. Science 277: 1662–1666.
[44]
Sakuma T, Ravin SS, Tonne JM, Thatava T, Ohmine S, et al. (2010) Characterization of retroviral and lentiviral vectors pseudotyped with XMRV envelope glycoprotein. Hum Gene Ther 12: 1665–1673.
[45]
Duggan J, Okonta H, Chakraborty J (2006) Transmission of Moloney murine leukemia virus (ts-1) by breast milk. J Gen Virol 87: 2679–2684.
[46]
Saha K, Hollowell D, Wong PK (1994) Mother-to-baby transfer of humoral immunity against retrovirus-induced neurologic disorders and immunodeficiency. Virology 198: 129–137.
[47]
Mirand EA, Grace JT Jr (1962) Transmission of Friend virus disease from infected mothers to offspring. Virology 16: 344–347.
[48]
Ida N, Moloney JB, Taylor G (1965) Vertical transmission of Moloney leukemia virus in A-LN and BALB-c strains of mice. Gann 56: 239–249.
[49]
Mirand EA, Grace JT, Buffett RF (1966) Passive and active immunity to Friend virus disease. Nature 209: 696–698.
[50]
Onlamoon N, Das Gupta J, Sharma P, Rogers K, Suppiah S, et al. (2011) Infection, viral dissemination, and antibody responses of rhesus macaques exposed to the human gammaretrovirus XMRV. J Virol 85: 4547–4557.
[51]
Paprotka T, Venkatachari NJ, Chaipan C, Burdick R, Delviks-Frankenberry KA, et al. (2010) Inhibition of Xenotropic Murine Leukemia Virus-Related Virus by APOBEC3 Proteins and Antiviral Drugs. J Virol.
[52]
Sakuma R, Sakuma T, Ohmine S, Silverman RH, Ikeda Y (2010) Xenotropic murine leukemia virus-related virus is susceptible to AZT. Virology 397: 1–6.
